Clinical trial
Production of Gamma-Interferon by Circulating Lymphocytes Exposed to Antigens Specific of Mycobacterium Tuberculosis: Contribution to the Identification of Latent Tuberculosis Infection in Contact Tracing
NCT00557765 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Production of Gamma-Interferon by Circulating Lymphocytes Exposed to Antigens Specific of Mycobacterium Tuberculosis: Contribution to the Identification of Latent Tuberculosis Infection in Contact Tracing
- Lead sponsor
- University Hospital, Geneva
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- January 31, 2006
- Enrollment
- 295 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
latent tuberculosis infection, tuberculosis